(Q34059392)

30 July 2017

1 reference

title

Metoprolol: a review of its use in chronic heart failure (English)

1 reference

30 July 2017

1 reference

chronic heart failure

1 reference

2

A Markham

0 references

author name string

A Prakash

series ordinal

1

1 reference

30 July 2017

A Markham

series ordinal

2

1 reference

30 July 2017

publication date

1 September 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

60

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

647-678

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200060030-00011

30 July 2017

exact match

0 references

cites work

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200060030-00011

Economics of treating heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200060030-00011

The evidence for beta blockers in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200060030-00011

beta-adrenergic receptor blockade in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200060030-00011

Enhancement of the bioavailability of propranolol and metoprolol by food

21 January 2018

1 reference

12 December 2020

Early reduction in plasma norepinephrine during beta-blocking therapy with metoprolol in chronic heart failure

1 reference

12 December 2020

Effect of controlled-release metoprolol on blood pressure and exercise heart rate in hypertension: a comparison with conventional tablets

1 reference

12 December 2020

Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients' characteristics: a meta-analysis of clinical trials

1 reference

12 December 2020

Short-term and long-term hemodynamic and clinical effects of metoprolol alone and combined with amlodipine in patients with chronic heart failure.

1 reference

12 December 2020

The role of beta-blockers in left ventricular dysfunction and heart failure

1 reference

12 December 2020

ABC of heart failure. Management: digoxin and other inotropes, beta blockers, and antiarrhythmic and antithrombotic treatment

1 reference

12 December 2020

Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol

1 reference

12 December 2020

Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Göteborg Metoprolol Trial)

1 reference

12 December 2020

Beta-blockade in heart failure: a comparison of carvedilol with metoprolol

1 reference

12 December 2020

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials

1 reference

12 December 2020

Design of a new multiple-unit controlled-release formulation of metoprolol--metoprolol CR

1 reference

12 December 2020

Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT)

1 reference

12 December 2020

The mortality effect of metoprolol CR/XL in patients with heart failure: results of the MERIT-HF Trial

1 reference

12 December 2020

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

1 reference

12 December 2020

Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure

1 reference

12 December 2020

What type of beta-blocker should be used to treat chronic heart failure?

1 reference

12 December 2020

Comparison of CYP2D6 content and metoprolol oxidation between microsomes isolated from human livers and small intestines

1 reference

12 December 2020

Metoprolol metabolism via cytochrome P4502D6 in ethnic populations

1 reference

12 December 2020

A sustained increase in beta-adrenoceptors during long-term therapy with metoprolol and bisoprolol in patients with heart failure from idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study

1 reference

12 December 2020

Effects of metoprolol on myocardial beta-adrenoceptors and Gi alpha-proteins in patients with congestive heart failure

1 reference

12 December 2020

Heart rate dependency of cardiac performance in heart failure patients treated with metoprolol

1 reference

12 December 2020

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

12 December 2020

Controlled release metoprolol. Clinical pharmacokinetic and therapeutic implications

1 reference

12 December 2020

The relationship between metoprolol plasma concentration and beta 1-blockade in healthy subjects: a study on conventional metoprolol and metoprolol CR/ZOK formulations

1 reference

12 December 2020

The cellular and physiologic effects of beta blockers in heart failure.

1 reference

12 December 2020

Pharmacokinetics of metoprolol enantiomers in Chinese subjects of major CYP2D6 genotypes

1 reference

12 December 2020

Beta-blockers for heart failure: is slowing of heart rate essential?

1 reference

12 December 2020

Are all beta-blockers for heart failure the same?

1 reference

12 December 2020

Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation

1 reference

12 December 2020

Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders

1 reference

12 December 2020

Improvement of exercise capacity and left ventricular diastolic function with metoprolol XL after acute myocardial infarction.

1 reference

12 December 2020

Efficacy and tolerability of a new controlled-release formulation of metoprolol: A comparison with conventional metoprolol tablets in mild to moderate hypertension

1 reference

12 December 2020

Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials

1 reference

12 December 2020

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

12 December 2020

Drug treatment in heart failure

1 reference

12 December 2020

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

12 December 2020

3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial. The Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

12 December 2020

Rationale, design, and organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF). The International Steering Committee

1 reference

12 December 2020

Experience with beta blockers in heart failure mortality trials.

1 reference

12 December 2020

Mechanism of action of beta-blocking agents in heart failure

1 reference

12 December 2020

BetaAdrenoceptor blockade in congestive heart failure: future perspectives

1 reference

12 December 2020

Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group

1 reference

12 December 2020

Effects of metoprolol on rest and exercise cardiac function and plasma catecholamines in chronic congestive heart failure secondary to ischemic or idiopathic cardiomyopathy

1 reference

12 December 2020

Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation

1 reference

12 December 2020

The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors

1 reference

12 December 2020

Effects of neurohormonal antagonism on symptoms and quality-of-life in heart failure.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol

1 reference

12 December 2020

Effect of metoprolol on the beta-adrenoceptor density of lymphocytes in patients with dilated cardiomyopathy

1 reference

12 December 2020

Beta blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol

1 reference

12 December 2020

Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial

1 reference

12 December 2020

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

12 December 2020

More favourable haemodynamic effects from metoprolol than from captopril in patients with dilated cardiomyopathy

1 reference

12 December 2020

Combined alpha-beta blockade (doxazosin plus metoprolol) compared with beta blockade alone in chronic congestive heart failure

1 reference

12 December 2020

Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade

1 reference

12 December 2020

Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials

1 reference

12 December 2020

Beta-blockers in heart failure. The 'new wave' of clinical trials

1 reference

12 December 2020

Consensus recommendations for the management of chronic heart failure

1 reference

12 December 2020

Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Beta-blocker therapy for heart failure: the evidence is in, now the work begins

1 reference

12 December 2020

Benefit of beta-blockers for heart failure: proven in 1999

1 reference

12 December 2020

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

12 December 2020

ABC of heart failure. Acute and chronic management strategies

1 reference

12 December 2020

Metoprolol CR/XL in patients with heart failure: A pilot study examining the tolerability, safety, and effect on left ventricular ejection fraction

1 reference

12 December 2020

Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure

1 reference

12 December 2020

Recovery from left ventricular asynergy in ischemic cardiomyopathy following long-term beta blockade treatment.

1 reference

12 December 2020

Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure

1 reference

12 December 2020

Beneficial effects of metoprolol treatment in congestive heart failure. Reversal of sympathetic-induced alterations of immunologic function

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: A comparison with conventional tablets

1 reference

12 December 2020

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

12 December 2020

Quality of life on treatment with metoprolol in dilated cardiomyopathy: results from the MDC trial. Metoprolol in Dilated Cardiomyopathy trial.

1 reference

12 December 2020

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

12 December 2020

Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure

1 reference

12 December 2020

10.2165/00003495-200060030-00011

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1017305308

0 references

Fatcat ID

release_6scpzhmydzfu7pjhfmc7cs55tq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6scpzhmydzfu7pjhfmc7cs55tq

24 November 2022

mapped directly with Wikidata item

1 reference